Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats (Q47851974)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 October 2017

Language	Label	Description	Also known as
English	Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats	scientific article published on 9 October 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Suresh Palle

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

Prasad Neerati

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

language of work or name

0 references

publication date

9 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

1-9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Dopamine: the forgotten felon in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Nanosizing--oral formulation development and biopharmaceutical evaluation

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Neuroprotective effects of quercetin in a mouse model of brain ischemic/reperfusion injury via anti-apoptotic mechanisms based on the Akt pathway

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

The colorimetric estimation of formaldehyde by means of the Hantzsch reaction

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

First-pass metabolism of midazolam by the human intestine.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Enhancement of oral bioavailability of rivastigmine with quercetin nanoparticles by inhibiting CYP3A4 and esterases

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Interactions of polyphenols with the P450 system: possible implications on human therapeutics

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Preparation of microsomes with calcium

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Pharmacokinetics and pharmacodynamics of bromocriptine in the rat.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Preparation and in-vitro evaluation of poly[N-vinyl-2-pyrrolidone-polyethylene glycol diacrylate]-chitosan interpolymeric pH-responsive hydrogels for oral drug delivery

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Cocrystals of quercetin with improved solubility and oral bioavailability

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Quercetin pretreatment increases the bioavailability of pioglitazone in rats: involvement of CYP3A inhibition

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Antidiabetic effects of quercetin in streptozocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Can grapefruit juice influence ethinylestradiol bioavailability?

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Interactions of herbs with cytochrome P450.

1 reference

https://api.crossref.org/works/10.1080%2F00498254.2017.1390277

21 January 2018

Identifiers

10.1080/00498254.2017.1390277

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28990837

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47851974&oldid=2172839158"